BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: 张泉成, 潘国政, 李国强, 袁庆忠, 徐教邦, 孔阳, 王立明. DC-CIK细胞治疗联合TACE及RFA治疗小肝癌的疗效. 世界华人消化杂志 2014; 22(16): 2237-2242 [DOI: 10.11569/wcjd.v22.i16.2237]
URL: https://www.wjgnet.com/1948-5182/full/v22/i16/2237.htm
Number Citing Articles
1
Guangzhi He, Chenhong Zheng, Huiping Huo, Huiming Zhang, Zhiquan Zhu, Junlai Li, Hongpeng Zhang. TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysisInternational Immunopharmacology 2016; 40: 436 doi: 10.1016/j.intimp.2016.09.015
2
CONG CHEN, YIN-HUA MA, YA-TING ZHANG, FAN ZHANG, NING ZHOU, XIANG WANG, TAO LIU, YU-MIN LI. Effect of dendritic cell–based immunotherapy on hepatocellular carcinoma: A systematic review and meta-analysisCytotherapy 2018; 20(8): 975 doi: 10.1016/j.jcyt.2018.06.002
3
Jiaxue Wang, Tiantian Shen, Qi Wang, Tan Zhang, Lujin Li, Yu Wang, Yi Fang. The long-term efficacy of cytokine-induced killer cellular therapy for hepatocellular carcinoma: a meta-analysisImmunotherapy 2019; 11(15): 1325 doi: 10.2217/imt-2019-0079
4
Xiu-Rong Cai, Xing Li, Jin-Xiang Lin, Tian-Tian Wang, Min Dong, Zhan-Hong Chen, Chang-Chang Jia, Ying-Fen Hong, Qu Lin, Xiang-Yuan Wu. Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic reviewOncotarget 2017; 8(19): 31318 doi: 10.18632/oncotarget.15454
5
Min Ding, Ying Wang, Jiachang Chi, Tao Wang, Xiaoyin Tang, Dan Cui, Qijun Qian, Bo Zhai, Beicheng Sun. Is Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 PatientsPLOS ONE 2016; 11(12): e0168798 doi: 10.1371/journal.pone.0168798